Sweden prioritizes psychological support for gender diverse youth The long anticipated new guidance from the Swedish National Board of Health and Welfare (NBHW) was released last week. In it, the NBHW concluded that the evidence base for medical interventions for gender diverse youth is of low quality, and that hormonal…
Update: May 5, 2021 The U-turn is official. Sweden has officially ended the practice of prescribing puberty blockers and cross-sex hormones for minors under age 18. They have recognized the experimental nature of treating minors with puberty blockers and hormones and have established new protocols that deviate significantly from WPATH…
Begin typing your search term above and press enter to search. Press ESC to cancel.
